Torrent Pharmaceuticals announced that the USFDA inspected its Dahej manufacturing unit from 19 January 2026 to 23 January 2026. The inspection concluded with Zero observations. Powered by Capital Market - Live News

Torrent Pharma has approved the issuance of Secured, Rated, Listed, Redeemable Non-Convertible Debentures (NCDs) aggregating upto Rs 12,500 crore in one or more tranches on private placement basis.Powered by Capital Market - Live News

Torrent Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 5 January 2026.Powered by Capital Market - Live News

Torrent Pharmaceuticals announced that commercial paper of Rs 200 crore has been redeemed and repaid by the company on maturity date i.e. 23 December 2025. Powered by Capital Market - Live News

Torrent Pharmaceuticals announced that NSE Sustainability Ratings and Analytics, a SEBI registered ESG Rating Provider, has independently assigned the Environmental, Social, and Governance (ESG) Rating of 70 to the Company.Powered by Capital Market - Live News